Free tool
FAERS Monitor: Ketalar
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 016812 or its brand name (Ketalar, Ketamine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
5,133
Serious
3,592
70% of reports
Hospitalization
1,603
Death reported
562
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- infusion site pain797
- drug ineffective564
- nausea545
- off label use539
- infusion site erythema501
- infusion site swelling347
- headache342
- diarrhoea317
- drug abuse315
- dyspnoea313
- hyperhidrosis238
- fatigue237
- sedation232
- infusion site haemorrhage227
- vomiting225
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 20 |
| 2005 | 20 |
| 2006 | 5 |
| 2007 | 35 |
| 2008 | 28 |
| 2009 | 59 |
| 2010 | 94 |
| 2011 | 61 |
| 2012 | 83 |
| 2013 | 84 |
| 2014 | 104 |
| 2015 | 94 |
| 2016 | 114 |
| 2017 | 84 |
| 2018 | 64 |
| 2019 | 143 |
| 2020 | 114 |
| 2021 | 194 |
| 2022 | 240 |
| 2023 | 563 |
| 2024 | 1,079 |
| 2025 | 1,106 |
| 2026 | 744 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,026 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| infusion site haemorrhageSignal | 227 | 303.6 | 266.1 | 63,475 |
| infusion site painSignal | 797 | 270.0 | 252.7 | 200,301 |
| infusion site erythemaSignal | 501 | 258.8 | 237.5 | 120,833 |
| infusion site swellingSignal | 347 | 239.1 | 215.3 | 77,544 |
| sedationSignal | 232 | 36.6 | 32.3 | 7,940 |
| drug abuseSignal | 315 | 15.6 | 14.0 | 4,278 |
| hyperhidrosisSignal | 238 | 7.6 | 6.7 | 1,359 |
| nauseaSignal | 545 | 2.8 | 2.6 | 664 |
| off label useSignal | 539 | 2.5 | 2.3 | 515 |
| dyspnoeaSignal | 313 | 2.3 | 2.0 | 226 |
| headacheSignal | 342 | 2.2 | 2.0 | 239 |
| diarrhoeaSignal | 317 | 2.0 | 1.8 | 166 |
| vomiting | 225 | 2.0 | 1.7 | 107 |
| drug ineffective | 564 | 1.8 | 1.6 | 194 |
| fatigue | 237 | 1.2 | 1.1 | 12 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.